OKYO Stock Summary and Trading Ideas (Okyo Pharma Limited - | NASDAQ:OKYO)

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

Okyo Pharma Limited - trades on the NASDAQ stock market under the symbol OKYO.

As of November 4, 2026, OKYO stock price declined to $1.43 with 80,649 million shares trading.

OKYO has a beta of 1.01, meaning it tends to be more sensitive to market movements. OKYO has a correlation of 0.04 to the broad based SPY ETF.

OKYO has a market cap of $75.05 million. This is considered a Micro Cap stock.

In the last 3 years, OKYO traded as high as $3.35 and as low as $.81.

OKYO has underperformed the market in the last year with a return of -47.0%, while the SPY ETF gained +13.6%. In the last 3 month period, OKYO fell short of the market, returning -14.4%, while SPY returned +1.7%. However, in the most recent 2 weeks OKYO has outperformed the stock market by returning +4.4%, while SPY returned -0.1%.

OKYO support price is $1.38 and resistance is $1.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKYO shares will trade within this expected range on the day.